Standout Papers

A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis 1994 2026 2004 2015 1.6k
  1. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis (1994)
    Gilbert Bensimon, Lucette Lacomblez et al. New England Journal of Medicine
  2. Dose-ranging study of riluzole in amyotrophic lateral sclerosis (1996)
    Lucette Lacomblez, Gilbert Bensimon et al. The Lancet
  3. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study (2008)
    Jean‐Philippe Collet, Jean‐Sébastien Hulot et al. The Lancet

Immediate Impact

4 by Nobel laureates 19 from Science/Nature 78 standout
Sub-graph 1 of 15

Citing Papers

Amyotrophic lateral sclerosis
2022 Standout
A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI
2019 Standout
33 intermediate papers

Works of Gilbert Bensimon being referenced

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
2018
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
2008 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Gilbert Bensimon 3682 1856 304 1326 46 5.9k
Haruo Okazaki 2870 1353 203 716 81 5.8k
Robert Sufit 4062 2314 130 1624 92 6.7k
Andrew G. Reaume 1693 797 116 3718 40 6.4k
Yadollah Harati 2057 572 87 912 71 3.7k
Álvaro G. Estévez 1439 628 112 1932 93 5.1k
Ralph W. Kuncl 3800 1288 185 3893 81 10.3k
M. A. Pericak‐Vance 810 1241 434 2638 55 7.0k
Edward J. Kasarskis 3035 1662 133 1381 109 5.7k
Stefan Vielhaber 2692 984 70 2058 166 5.7k
R G Smith 1501 553 118 1704 76 6.1k

All Works

Loading papers...

Rankless by CCL
2026